NeuroNexus Technologies and Philips partner to research deep brain stimulation devices
Philips, November 18, 2008
NeuroNexus Technologies and Philips Research have announced that they have signed a joint research agreement to develop next-generation deep brain stimulation devices with the ambition to improve the treatment of neurological diseases and psychiatric disorders. The two companies aim to show the technical feasibility of highly programmable and MRI-safe deep brain stimulation devices, according to a release. Their initial research will aim to meet the functional requirements of a deep brain stimulation device for the treatment of Parkinson?s disease.
- Providers Lag as Consumers Set Agenda
- Look Beyond Nurse-Patient Ratios
- Esther Dyson Launches Population Health Challenge
- Reform Puts Vise Grips on Physicians
- Crisis Spurs Healthcare Payment Reform in Arkansas
- Hospital Groups Back NQF Report on Patient Sociodemographics
- ICD-10 Delay Alters Provider, Vendor Prep
- NPP Demand Rising Under Value-Based Care Models
- Medicare Opt-Out a Viable Physician Strategy
- Reduce Readmissions by Activating Patients to Do 'Self-Care'